HIMS stock has experienced significant movement recently, showing a big move off the 50% retrace after filling the Q1 earnings gap. The stock has also filled the overhead gap and is back over the 21-day moving average. Traders have been actively trading HIMS, with some locking in gains at 16.5 and others preparing for potential upward movements from the 14 area. One trader mentioned being in equity only and making good $. Additionally, HIMS stock has risen following the acquisition of Nivagen Pharmaceuticals.